Olha Holubovska Raises Alarm Over Potential Medicine Crisis Following Russian Attacks
Olha Holubovska, President of the All-Ukrainian Association of Infectious Disease Specialists, warns of a severe shortage of medicines in Ukraine triggered by Russian missile strikes on pharmaceutical warehouses, including the destruction of the "Biocon" storage complex. She criticizes the lack of government-operated storage hubs and points to systemic unpreparedness within the Ministry of Health (MOH), urging the establishment of a strategic drug reserve alongside transparent inventory management.
Holubovska highlights Ukraine's heavy reliance on imported medications, especially those used to treat cancer, rare diseases, and patients undergoing immunobiological therapy. Although in June 2026 the Cabinet of Ministers authorized "Medical Purchases of Ukraine" to create a reserve for certain critical medicines, current measures fall short of meeting the population's needs.
"HOW SHOULD WE ADDRESS THE THREAT OF A CRITICAL DRUG SHORTAGE? DOES THE MINISTRY OF HEALTH HAVE A PLAN?" Holubovska asks.
She stresses that depending entirely on private pharmaceutical logistics without state-owned storage and distribution infrastructure is a catastrophic oversight. "For years, the government has shifted this responsibility onto the private sector, now leaving itself as a passive observer," she adds.
For patients, the absence of essential medicines is more than an inconvenience—it poses a direct risk to their lives. Holubovska insists that the MOH must clearly communicate which drugs are currently unavailable, expected restocking timelines, and specific strategies to cover shortages for those with severe illnesses. "Ukraine needs a protected, decentralized strategic drug reserve with real-time, transparent electronic stock tracking," she emphasizes.
Urgent Overhaul of Pharmaceutical Logistics Required
"A swift restructuring of the logistics system is critical," Holubovska urges, emphasizing that the Ministry must work closely with distributors to rapidly redistribute available supplies. The government should also streamline the import process for medication alternatives by removing bureaucratic obstacles that delay border crossings. "Patients on ongoing or specialized treatments must maintain a rotating stockpile sufficient for several weeks or months ahead," she advises.
Holubovska also recommends that patients proactively consult their healthcare providers to agree on interchangeable drugs based on international nonproprietary names (active ingredients) in case their usual brands temporarily vanish from pharmacies. These measures are vital for ensuring continuous access to necessary treatments during crisis conditions.
The current medicine shortage in Ukraine stems not only from Russian missile attacks but also from systemic vulnerabilities within the healthcare system. This situation underscores the urgent need to improve logistics and reserve mechanisms. Given the critical importance of protecting vulnerable populations' access to medication, the Ministry of Health and government actions will be pivotal in stabilizing medical supplies nationwide. Establishing a strategic drug reserve combined with transparent inventory tracking will be essential to preventing future crises.
In light of the ongoing missile strikes, the Ukrainian government has recently relaxed regulations regarding medicine storage. This move aims to address the immediate challenges posed by the destruction of pharmaceutical facilities and the urgent need for effective drug management. For a deeper understanding of how these regulatory changes could impact the availability of essential medications, read more about the adjustments in medicine storage policies amidst the crisis.